Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Oncology Nutrition Market

Oncology Nutrition Market Size

  • Report ID: GMI9015
  • Published Date: Apr 2024
  • Report Format: PDF

Oncology Nutrition Market Size

Oncology Nutrition Market size was valued at USD 2.1 billion in 2023 growing at a CAGR of 8.1% between 2024 and 2032, driven by factors such as the rising global prevalence of cancer that fuels the demand for specialized nutritional products and services to support cancer patients before, during, and after treatment.

 

For instance, as per the report published by World Health Organization in February 2024, it has been reported that, in 2022, the estimated number of people who were alive within 5 years following a cancer diagnosis was 53.5 million. In addition, about 1 in 5 people develop cancer in their lifetime. Thus, the rapid increase in the prevalence of cancer globally is expected to increase the demand for nutrition products that propel the growth of the market in upcoming years.
 

Moreover, the growing awareness of nutrition in cancer management to manage side effects, improve treatment tolerance, and enhance quality of life during cancer therapy is expected to boost the market growth. Oncology nutrition focuses on providing a balanced and tailored diet for cancer patients, essential for supporting overall health, enhancing recovery, and managing the side effects of cancer treatments. It is based on increasing the patient’s intake of protein and calories with small amounts of hot or cold food that is highly nutritious and easy to digest.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Oncology nutrition industry size recorded USD 2.1 billion in 2023 and is expected to register 8.1% CAGR from 2024 to 2032, due to the rising global prevalence of cancer.

The stomach and gastrointestinal cancer segment in the market accounted for USD 472 million in revenue in 2023, owing to poor dietary habits like high consumption of processed foods, red meats, and low intake of fruits and vegetables.

North America oncology nutrition industry held 42.7% revenue share in 2023 and is expected to depict substantial growth from 2024 to 2032, led by the increasing prevalence of cancer and the growing number of cancer survivors.

Abbott Laboratories, Baxter International Inc., B. Braun Melsungen AG, Danone (Nutricia), Fresenius SE & Co. KGaA, Grifol S.A., Hormel Foods Corporation, Meiji Holdings Co., Ltd., Medtrition Inc., Nestle S.A., and Victus, Inc. are some of the major oncology nutrition companies worldwide.

Oncology Nutrition Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 230
  • Countries covered: 19
  • Pages: 140
 Download Free Sample